Kicker Ventures is a venture capital investment firm founded in 2021 and based in Menlo Park, California. The firm specializes in investing in early-stage companies, specifically those in the healthcare sector, focusing on pre-seed to Series A stages. Kicker Ventures aims to support innovation in healthcare technology systems, digital health, and healthcare devices and supplies. In addition to its investment activities, the firm offers various programs designed to foster collaboration and growth, including co-studio initiatives, global fit assessments, advisor-in-residence opportunities, and corporate fellowships.
Colabra specializes in enhancing the efficiency of scientific teams through its development of data integration and collaboration tools. The company provides a platform that facilitates real-time collaboration, allows for the integration of diverse data sources, and supports agile project management. This enables scientific researchers to effectively track their workflows, share data, and communicate outcomes. By streamlining these processes, Colabra aims to eliminate inefficiencies and boost research productivity, ultimately fostering a more innovative approach to scientific research and development.
Talofa
Seed Round in 2024
Talofa is building games that make players mentally and physically healthier. Their flagship game on the platform, Run Legends, got over 300,000 downloads in the first 3 months and was featured as one of the "Best New Games" by Apple and Google Play Stores. Talofa’s team has been built up with game veterans from EA, 2K, and Riot Games and the CEO, Jenny Xu, has created mobile games with over 10M downloads.
Anise Health
Pre Seed Round in 2023
Anise Health operates a digital platform that offers culturally-responsive mental health care tailored to the needs of people of color. The platform provides a range of services, including therapy, behavioral coaching, and self-guided tools, aimed at addressing issues such as minority stress, low self-worth, guilt, shame, and negative emotions. Anise Health's approach has demonstrated a fivefold increase in effectiveness compared to traditional one-size-fits-all methods. Additionally, the platform enables communities to measure progress, monitor personal growth, and support long-term well-being.
Do. Sukasu
Venture Round in 2023
Do. Sukasu is a software company that specializes in the development of visual space perception ability for brain science approaches.
Gravel AI
Seed Round in 2023
Gravel AI is a developer of a data intelligence platform focused on the chemical manufacturing sector. The platform leverages artificial intelligence to provide detailed insights into chemical consumption, helping manufacturers and brands identify and unlock demand in both new and existing markets. By analyzing formulation change patterns, ingredient substitution activities, and product survival rates, Gravel AI generates comprehensive data on cosmetics ingredient market trends. This enables decision-makers within chemical manufacturing to make informed choices that drive business growth and enhance their understanding of market dynamics.
Ruby Bio
Seed Round in 2022
Ruby Bio is a biosynthesis platform focused on the production of complex, biodegradable, and non-toxic molecules. Utilizing naturally occurring yeast, the company transforms low-cost sugars into high-value products. This innovative approach allows Ruby Bio to support the creation of sustainable alternatives in personal care, home care, food, and beverage industries. By harnessing the power of biosynthesis, Ruby Bio aims to contribute to environmentally friendly solutions while addressing the growing demand for sustainable products.
Swing Therapeutics
Series A in 2022
Swing Therapeutics focuses on developing innovative digital therapeutics aimed at helping individuals with chronic conditions. The company collaborates with leading researchers to create evidence-based treatments that enhance patient empowerment and control over their health. By offering novel prescription digital therapeutics, Swing supports patients in managing their illnesses more effectively, ultimately fostering improved health outcomes and promoting a more vibrant quality of life.
Behavidence
Seed Round in 2022
Behavidence is a technology company that focuses on diagnosing and monitoring mental health conditions through the use of artificial intelligence. By analyzing subtle changes in phone usage patterns, Behavidence provides AI models for conditions such as Depression, Anxiety, Stress, ADHD, and PPD. The platform is designed for adoption by health organizations, technology firms, and government entities worldwide. Its applications extend beyond screening to include remote monitoring, detection of comorbidities, and assessment of therapeutic efficacy and potential relapses. Behavidence emphasizes user privacy, ensuring minimal burden on respondents while delivering real-time feedback. Through digital phenotyping and machine learning algorithms, the company offers high-accuracy tools to enhance the quality of care for users, caregivers, and clinical therapists.
Woebot Health
Series B in 2021
Woebot Health is a digital mental healthcare provider that focuses on delivering personalized support through an innovative platform. This platform integrates advanced artificial intelligence and natural language processing with established therapeutic techniques to create engaging mental health tools. At the core of its offering is Woebot, a relational agent designed to provide continuous, empathic, and personalized care. By leveraging these technologies, Woebot Health enables individuals and businesses to access effective mental health support conveniently and seamlessly, fitting into everyday life and promoting overall well-being.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.